Winton Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
$20.2M Buy
1,493,017
+1,143,050
+327% +$15M 0.14% 262
2013
Q4
$4.21M Buy
349,967
+215,800
+161% +$2.55M 0.04% 386
2013
Q3
$1.57M Buy
134,167
+11,012
+9% +$119K 0.02% 457
2013
Q2
$1.14M Buy
+123,155
New +$1.04M 0.01% 481

Other funds holding BSX

Winton Capital Management's BSX Position: Q1 2014 in Review

Winton Capital Management increased its Boston Scientific (BSX) stake by 327% in Q1 2014, buying an estimated $15M and bringing the position to 1,493,017 shares worth $20.2M. The position accounts for 0.14% of the portfolio, ranked #262.

Winton Capital Management first reported a position in BSX in Q2 2013 and has held it in 4 quarters since. 440 funds tracked by Wall St. Rank hold BSX as of Q1 2014.

  • Winton Capital Management held 1,493,017 shares of Boston Scientific worth $20.2M as of Q1 2014.
  • Winton Capital Management bought 1,143,050 Boston Scientific shares in Q1 2014, an estimated $15M.
  • Boston Scientific made up 0.14% of Winton Capital Management's portfolio in Q1 2014, its #262 holding.
  • Winton Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 4 quarters since.
  • 440 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.